111 related articles for article (PubMed ID: 36098711)
1. The expression of miR-181b, CYLD, CBX-7, BCL2, and p53 in osteosarcoma patients and correlation with clinicopathological factors.
Fazli J; Fattah K; Moliani A; Valizadeh A; Bazavar M
Chem Biol Drug Des; 2023 Jan; 101(1):2-8. PubMed ID: 36098711
[TBL] [Abstract][Full Text] [Related]
2. Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin.
Hosseini F; Shanehbandi D; Soleimanpour J; Yousefi B; Alemi F
Drug Res (Stuttg); 2022 Jul; 72(6):312-318. PubMed ID: 35636434
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.
He M; Gao L; Zhang S; Tao L; Wang J; Yang J; Zhu M
Gastric Cancer; 2014; 17(3):431-41. PubMed ID: 24232982
[TBL] [Abstract][Full Text] [Related]
4. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis.
Wang W; Wang Z; Chen S; Zang X; Miao J
J Cell Biochem; 2019 Feb; 120(2):1763-1772. PubMed ID: 30977354
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of tumor miR-21, miR-221, miR-143, and miR-106a as biomarkers in patients with osteosarcoma.
Zhao H; Yan P; Wang J; Zhang Y; Zhang M; Wang Z; Fu Q; Liang W
Int J Biol Markers; 2019 Jun; 34(2):184-193. PubMed ID: 31084400
[TBL] [Abstract][Full Text] [Related]
8. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
10. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma.
Taheriazam A; Talaei AJ; Jamshidi M; Shakeri M; Khoshbakht S; Yahaghi E; Shokrani M
Diagn Pathol; 2015 Oct; 10():184. PubMed ID: 26446495
[TBL] [Abstract][Full Text] [Related]
12. Quercetin and Methotrexate in Combination have Anticancer Activity in Osteosarcoma Cells and Repress Oncogenic MicroRNA-223.
Mohammadi E; Alemi F; Maleki M; Malakoti F; Farsad-Akhtar N; Yousefi B
Drug Res (Stuttg); 2022 Apr; 72(4):226-233. PubMed ID: 35385884
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
14. [miR-181a promotes the proliferation and metastasis of osteosarcoma cells by targeting RASSF1A].
Zang X; Li Q; Wang W; Zhou Y; Chen S; Xiao T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 41(8):789-95. PubMed ID: 27600004
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181a-5p Promotes Osteosarcoma Progression via PTEN/AKT Pathway.
Sun C; Chen C; Chen Z; Guo J; Yu ZH; Qian W; Ai F; Xiao L; Guo X
Anal Cell Pathol (Amst); 2022; 2022():3421600. PubMed ID: 35310933
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.
Jianwei Z; Fan L; Xiancheng L; Enzhong B; Shuai L; Can L
Tumour Biol; 2013 Dec; 34(6):3331-7. PubMed ID: 23740615
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway.
Yang X; Sun Y; Zhang Y; Han S
Int J Mol Med; 2020 Nov; 46(5):1755-1764. PubMed ID: 32901872
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
Hong Q; Fang J; Pang Y; Zheng J
Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma.
Liu Y; Cheng Z; Pan F; Yan W
Oncol Res; 2017 Jul; 25(6):989-999. PubMed ID: 28244849
[TBL] [Abstract][Full Text] [Related]
20. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
